|
Date
|
Time
|
Title
|
Chairperson(s)
|
Room
|
|
30 Aug 2008 |
12:00-15:30 |
Cardiovascular risk management - From prevention to treatment
Satellite Symposium organised by Bayer Schering Pharma AG
|
L Ryden (Stockholm, SE), M Tendera (Katowice, PL) |
Brussels - Zone A1 |
|
30 Aug 2008 |
12:00-13:30 |
Tackling atherosclerosis in high risk patients: how rimonabant is setting new standards
Satellite Symposium organised by sanofi-aventis |
J-P Bassand (Besancon, FR), P G Steg (Paris, FR) |
Madrid - Zone A1 |
|
30 Aug 2008 |
12:00-13:30 |
Combination treatment in hypertension
Satellite Symposium organised by Recordati and Berlin-Chemie/Menarini Group |
G Mancia (Milan, IT), R Ferrari (Ferrara, IT) |
Cairo - Zone B1 |
 |
30 Aug 2008 |
12:00-13:30 |
Optimising pharmacological therapy for at-risk acute coronary syndromes patients
Satellite Symposium organised by Iroko Pharmaceuticals in collaboration with MSD
|
E Braunwald (Boston, US), C W Hamm (Bad Nauheim, DE) |
Stockholm - Zone B1 |
|
30 Aug 2008 |
12:00-13:30 |
New developments in cardiac computed tomography diagnosis
Satellite Symposium organised by Toshiba Medical Systems |
W Rutsch (Berlin, DE), J J Bax (Leiden, NL) |
Vienna - Zone A4 |
|
30 Aug 2008 |
12:00-15:30 |
Know the score: best practices in reducing cardiovascular mortality
Satellite Symposium organised by Pfizer Inc. |
Chairperson(s) : J C Geller (Bad Berka, DE), A M Heagerty (Manchester, GB) |
Paris - Zone B1 |
|
30 Aug 2008 |
14:00-15:30 |
Key lessons from morbidity/mortality trials: Evidence for benefits of the perindopril/amlodipine combination
Satellite Symposium organised by Servier |
R Ferrari (Ferrara, IT), G Mancia (Milan, IT) |
London & The Hague - Zone B4 |
|
30 Aug 2008 |
14:00-15:30 |
Leading innovations in ultrasound cardiac imaging
Satellite Symposium organised by Toshiba Medical Systems |
J Gorcsan (Pittsburgh, US), H-J Nesser (Linz, AT) |
Vienna - Zone A4 |
|
30 Aug 2008 |
14:30-16:00 |
Why Inhibiting Cholesterol Absorption and Production is Today's Treatment Standard
Satellite Symposia organised by Merck Sharp & Dohme / Schering-Plough |
T R Pedersen (Oslo, NO), A K Gitt (Ludwigshafen, DE) |
Stockholm - Zone B1 |
|
30 Aug 2008 |
14:30-16:00 |
Second generation drug eluting stents and the implications of change
Satellite Symposium organised by Abbott Vascular International |
P W Serruys (Rotterdam, NL), C W Hamm (Bad Nauheim, DE) |
Berlin - Zone A3 |
|
30 Aug 2008 |
14:30-16:00 |
Preclinical and clinical aspects of autologous stem cell therapy
Satellite Symposium organised by Miltenyi Biotec |
J Bartunek (Aalst, BE), K-H Kuck (Hamburg, DE) |
Oslo- Zone A1 |
|
30 Aug 2008 |
14:30-16:00 |
From hypertension to protection: contribution of angiotensin receptor blockers in the fight against cardiovascular disease
Satellite Symposium organised by Daiichi Sankyo Europe GmbH & Menarini International |
C M Ferrario (Winston-Salem, US), R Schmieder (Erlangen, DE) |
Cairo - Zone B1 |
|
30 Aug 2008 |
14:30-16:00 |
Revolutionary cardiac imaging technologies for improved patient care in Coronary Artery Disease
Satellite Symposium organised by Siemens AG Healthcare |
P J De Feyter (Rotterdam, NL), J Mair (Innsbruck, AT) |
Copenhagen - Zone B3 |
|
30 Aug 2008 |
14:30-16:00 |
A step beyond: an innovative approach to anticoagulation management
Satellite Symposium organised by sanofi-aventis
|
H R Bueller (Amsterdam, NL), FWA Verheugt (Nijmegen, NL) |
Budapest - Zone A1 |
|
30 Aug 2008 |
14:30-16:00 |
Cardiac insights in recurrent stroke prevention
Satellite Symposium organised by Boehringer Ingelheim |
H C Diener (Essen, DE), S Yusuf (Hamilton, CA) |
Ankara - Zone B3 |
|
30 Aug 2008 |
14:30-16:00 |
Impact of modern diagnostic tools in pulmonary arterial hypertension
Satellite Symposium organised by Bayer Schering Pharma AG |
N Galie (Bologna, IT), C F Opitz (Berlin, DE) |
Prague - Zone B3 |
|
30 Aug 2008 |
14:30-16:00 |
Latest advances in 2D and live 3D echocardiography
Satellite Symposium organised by Philips Healthcare
|
M Pepi (Milan, IT), H P Kuehl (Aachen, DE) |
Bucharest - Zone A4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
31 Aug 2008 |
12:45-13:30 |
Novel approaches to stroke prevention in patients with atrial fibrillation
Satellite Symposium organised by Boehringer Ingelheim |
P G Steg (Paris, FR), J Weitz (Hamilton, CA) |
Cairo - Zone B1 |
|
31 Aug 2008 |
12:45-13:30 |
A multidisciplinary approach in the management of the patient at cardiometabolic risk
Satellite Symposium organised by sanofi-aventis |
I M Graham (Dublin, IE), S Smith (Chapel Hill, US) |
Budapest - Zone A1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
01 Sep 2008 |
18:30-20:00 |
Survival benefits of aldosterone blockade: expanding the standards of care for congestive heart failure post-myocardial infarction
Satellite Symposium organised by Pfizer Inc. |
H Drexler (Hannover, DE), M Komajda (Paris, FR) |
Prague - Zone B3 |
|
01 Sep 2008 |
18:30-20:00 |
The heart of the matter
Satellite Symposium organised by Menarini |
R Kolloch (Bielefeld, DE), M Tendera (Katowice, PL) |
Warsaw - Zone A3 |
|
01 Sep 2008 |
18:30-20:00 |
New standards in protecting high risk patients: learnings from the ONTARGET programme
Satellite Symposium organised by Boehringer Ingelheim and Bayer Schering Pharma
|
S Yusuf (Hamilton, CA), F Zannad (Vandoeuvre-Les-Nancy, FR) |
Munich - Zone A4 |
|
01 Sep 2008 |
18:30-20:00 |
The heart of the matter: evidence-based anticoagulant therapy across the spectrum of acute coronary syndromes
Satellite Symposium organised by sanofi-aventis |
J S Alpert (Tucson, US), K A Fox (Edinburgh, GB) |
Budapest - Zone A1 |
|
01 Sep 2008 |
18:30-20:00 |
New strategies for acute coronary syndromes: exploring the role of oral factor Xa inhibition
Satellite Symposium organised by Pfizer Inc and Bristol-Myers Squibb |
R A Harrington (Durham, US), K Huber (Vienna, AT) |
Cairo - Zone B1 |
|
01 Sep 2008 |
18:30-20:00 |
Heart rate throughout the cardiovascular continuum
Satellite Symposium organised by Servier
|
K M Fox (London, GB), G Heusch (Essen, DE) |
London & The Hague - Zone B4 |
|
01 Sep 2008 |
18:30-20:00 |
Moving forward in pulmonary arterial hypertension
Satellite Symposium organised by GlaxoSmithKline |
S Gaine (Dublin, IE), S Gibbs (London, GB) |
Copenhagen - Zone B3 |
|
01 Sep 2008 |
18:30-20:00 |
Beta-blockade across the cardiovascular continuum: when and where to use?
Satellite Symposium organised by Merck Serono, a division of Merck KGaA |
Chairperson(s) : R Willenheimer (Malmo, SE), E Erdmann (Koeln, DE) |
Tel Aviv - Zone B1 |
|
01 Sep 2008 |
18:30-20:00 |
Selective factor Xa inhibition and cardiovascular mortality reduction
Satellite Symposium organised by GlaxoSmithKline |
J-P Bassand (Besancon, FR), F Van de Werf (Leuven, BE) |
Ankara - Zone B3 |
|
01 Sep 2008 |
18:30-20:00 |
Antiplatelet therapy for acute coronary syndromes (ACS) treated with percutaneous coronary interventions (PCI): new developments
Satellite Symposium organised by Daiichi Sankyo Europe GmbH & Eli Lilly and Company |
J L Lopez-Sendon (Madrid, ES), R F Storey (Sheffield, GB) |
Madrid - Zone A1 |
|
01 Sep 2008 |
18:30-20:00 |
Improving cardiovascular outcomes in atrial fibrillation
Satellite Symposium organised by sanofi-aventis |
J G F Cleland (Kingston upon Hull, GB), R H Falk (Boston, US) |
Berlin - Zone A3 |
|
01 Sep 2008 |
18:30-20:00 |
Improving cardiovascular risk management: overcoming the hurdles of hypertension, diabetes and renal dysfunction
Satellite Symposium organised by Novartis
|
R Duesing (Bonn, DE), M A Weber (New York, US) |
Athens - Zone B3 |
|
01 Sep 2008 |
18:30-20:00 |
Anticoagulant therapy: new perspectives in cardiovascular medicine
Satellite Symposium organised by Bayer Healthcare AG and Scios Inc. |
C Bode (Freiburg, DE), FWA Verheugt (Nijmegen, NL) |
Oslo- Zone A1 |
|
01 Sep 2008 |
18:30-20:00 |
The challenge of renal protection in acute decompensated heart failure
Satellite Symposium organised by Merck Sharp & Dohme
|
M Gheorghiade (Chicago, US), K Werdan (Halle, DE) |
Stockholm - Zone B1 |
|
01 Sep 2008 |
18:30-20:00 |
Prevalent coronary heart disease and the diabetic eye. Focus on management of your patient with type 2 diabetes
Satellite Symposium organised by Solvay Pharmaceuticals |
G Assmann (Munster, DE), R Rosenson (Chicago, US) |
Bucharest - Zone A4 |
|
01 Sep 2008 |
18:30-20:00 |
The changing role of cardiac ultrasound in cardiomyopathies
Satellite Symposium organised by GE Healthcare |
F Flachskampf (Erlangen, DE), L A Brodin (Huddinge, SE) |
Vienna - Zone A4 |
|
01 Sep 2008 |
18:30-20:00 |
Current challenges and future opportunities in managing atherothrombosis risk
Satellite Symposium organised by GlaxoSmithKline |
P Libby (Boston, US), W Koenig (Ulm, DE) |
Lisbon - Zone C |
|
01 Sep 2008 |
18:30-20:00 |
Landmark practice advances in ST-Elevation Myocardial Infarction (STEMI) and acute coronary syndrome (ACS): consistent and unified management strategies for 2008 and beyond - What do new trials tell us about care for high risk ACS?
Satellite Symposium organised by The Medicines Company |
S Savonitto (Milano, IT), C Di Mario (London, GB) |
Helsinki - Zone A3 |
|
|
|
|
|
|
|
|
02 Sep 2008 |
14:00-15:30 |
A novel approach to multiple organ protection
Satellite Symposium organised by Takeda Pharmaceuticals Europe Limited
|
M R Cowie (London, GB), A P Maggioni (Florence, IT) |
Vienna - Zone A4 |
|
02 Sep 2008 |
14:00-15:30 |
The importance of time in the treatment of acute ST-elevated myocardial infarction
Satellite Symposium organised by Boehringer Ingelheim
|
K Huber (Vienna, AT), HR Arntz (Berlin, DE) |
Ankara - Zone B3 |